Pregnancy with type 1 diabetes is safest when planned — pre-pregnancy A1C below 6.5 percent, folate supplementation, and complication screening before conception substantially reduce risks. Insulin requirements typically drop modestly in the first trimester (more hypoglycemia), stabilize briefly, then rise 50 to 100 percent by the third trimester. Continuous glucose monitor use is strongly recommended, with pregnancy-specific targets (fasting under 95 mg/dL, 1-hour post-meal under 140 mg/dL, time in range 63 to 140 mg/dL above 70 percent). Multidisciplinary care from preconception through postpartum — endocrinologist, maternal-fetal medicine, diabetes educator — produces the best outcomes.
Why Planning Matters
The first 6 to 10 weeks of pregnancy — when most major organs form — usually happens before a woman knows she is pregnant. Glucose control during this window correlates strongly with the risk of congenital anomalies, miscarriage, and other adverse outcomes. Planning ahead allows:
- Target A1C reached before conception, not chased after
- Folate supplementation in place for neural tube development (400 to 1000 mcg daily, ideally for 3 months pre-conception)
- Medication review and changes (stop ACE inhibitors, ARBs, statins; review thyroid medication)
- Complication screening — dilated eye exam, kidney function, blood pressure, thyroid
- Establish care with a maternal-fetal medicine specialist or high-risk OB
- Address smoking, alcohol, weight
- Mental health assessment and support
Preconception Checklist
| Item | Detail |
|---|---|
| A1C target | <6.5% (some specialists target <6.0% if safe) |
| Folate | 400–1000 mcg daily; higher (4 mg) if prior neural tube defect pregnancy |
| Eye exam | Dilated retinal exam; pregnancy can worsen retinopathy |
| Kidney function | UACR, creatinine, eGFR |
| Thyroid | TSH; women with T1D often have autoimmune thyroid disease |
| Blood pressure | Treat to target; switch off ACE/ARB before conception |
| Statin | Discontinue; not used during pregnancy |
| Vaccinations | Rubella, varicella, hepatitis B, flu, Tdap status |
| Smoking, alcohol | Cessation |
| Weight | Optimize before conception |
| Contraception | Reliable method until ready and A1C controlled |
For broader context see our article on preconception diabetes care.
Pregnancy Glucose Targets
Targets are tighter than non-pregnant targets because elevated maternal glucose drives fetal complications.
- Fasting / pre-meal: 70 to 95 mg/dL
- 1-hour post-meal: <140 mg/dL
- 2-hour post-meal: <120 mg/dL
- A1C: <6.0 to 6.5%, individualized to avoid hypoglycemia
- Time in range (63 to 140 mg/dL): >70%
- Time below 63 mg/dL: <4%
- Time below 54 mg/dL: <1%
- Time above 140 mg/dL: <25%
How Insulin Needs Change by Trimester
| Trimester | Typical Insulin Change |
|---|---|
| Weeks 1–8 | Slight decrease; hypoglycemia risk higher |
| Weeks 8–16 | Continued lower needs in many women; relative stability |
| Weeks 16–28 | Steady rise begins; placental hormones increase insulin resistance |
| Weeks 28–36 | Sharp rise; total insulin often 50–100% above pre-pregnancy |
| Weeks 36–delivery | Often plateaus or slight decrease near term |
| Immediately postpartum | Rapid drop — usually below pre-pregnancy needs |
| Breastfeeding | Insulin needs often 10–20% below pre-pregnancy |
The third-trimester rise can be dramatic — basal rates may double, mealtime ratios may halve. Frequent contact with the diabetes team (often weekly) is needed to keep up with the changes.
CGM in Pregnancy: The CONCEPTT Results
The CONCEPTT trial (Feig 2017) randomized over 300 pregnant women with T1D to CGM versus standard finger-stick monitoring. Results:
- Modest A1C improvement in CGM group (~0.2%)
- Reduced large-for-gestational-age babies
- Lower rate of NICU admission beyond 24 hours
- Less neonatal hypoglycemia
- One-day shorter average hospital stay
CGM is now standard of care in T1D pregnancy. Dexcom G6 and G7, Freestyle Libre 2 and 3 are all used. Sensor changes happen more frequently due to skin sensitivity in pregnancy; accuracy is generally maintained.
Insulin Pumps in Pregnancy
- Tandem t:slim X2 with Control-IQ pregnancy algorithm: First FDA-approved pregnancy-specific hybrid closed-loop algorithm (more recent approval); pregnancy mode targets pregnancy-appropriate glucose
- Omnipod 5: Used off-label; not FDA-approved with pregnancy algorithm
- Medtronic 780G: Used off-label internationally and in US
- Standard pumps without closed-loop: Still widely used; multiple basal profiles for trimester changes
- Multiple daily injections (MDI): Long-acting (insulin detemir is most-studied in pregnancy; glargine increasingly accepted) plus rapid-acting at meals
- Rapid-acting choices: Aspart and lispro extensively used; faster aspart (Fiasp) also used
Risks Associated with Diabetes in Pregnancy
- Congenital anomalies: Heart defects, neural tube defects — risk correlates with first-trimester A1C
- Miscarriage: Higher with elevated A1C
- Macrosomia (large baby): Driven by maternal hyperglycemia → fetal hyperinsulinemia → fetal growth
- Preeclampsia: 2 to 4 times more common in T1D pregnancy
- Polyhydramnios: Excess amniotic fluid
- Preterm delivery: Both spontaneous and indicated
- Neonatal hypoglycemia: Common, monitored after birth
- Neonatal respiratory distress, jaundice
- Shoulder dystocia: Birth injury risk with macrosomia
- Maternal hypoglycemia: Increased risk in early pregnancy; hypoglycemia unawareness can worsen
- Diabetic ketoacidosis: Pregnancy increases risk; can occur at lower glucose levels (euglycemic DKA)
Eye and Kidney Considerations
Diabetic complications can progress during pregnancy.
- Retinopathy: Dilated exam before pregnancy and in each trimester. Rapid A1C lowering can transiently worsen retinopathy — gradual improvement is preferred.
- Nephropathy: UACR at baseline. Microalbuminuria may worsen in pregnancy; significant proteinuria raises preeclampsia and growth restriction risk.
- Neuropathy: Existing autonomic neuropathy may complicate management of nausea, gastroparesis, hypoglycemia awareness.
Nutrition in Pregnancy with T1D
- Adequate calories — typically 30 kcal/kg in second and third trimester
- Consistent carbohydrate timing and amount per meal to allow accurate insulin dosing
- About 175 g carb per day minimum (vs. ketogenic diets, which are not recommended)
- Protein 1.1 g/kg per day
- Folate, iron, calcium, vitamin D, DHA
- Caffeine limited (under 200 mg/day)
- Avoid alcohol completely
- Listeriosis precautions (raw cheese, deli meats, raw seafood)
- Frequent small meals often help avoid spikes
Hypoglycemia in Pregnancy
- Risk is highest in first trimester
- Hypoglycemia unawareness can develop or worsen
- Nasal glucagon (Baqsimi) and injectable glucagon (Gvoke) safe for use
- Partner/family should know how to administer glucagon
- CGM alarm thresholds set tighter
- Snacks at bedside for overnight lows
- Severe maternal hypoglycemia does not appear to harm fetal development directly, but accidents and trauma risk warrant prevention
Fetal Monitoring
- Early ultrasound to confirm dating
- Detailed anatomy scan around 20 weeks
- Fetal echocardiogram around 22 weeks
- Growth ultrasounds in third trimester
- Non-stress tests and biophysical profiles in third trimester
- Kick counts
Delivery Planning
- Most women with T1D deliver between 37 and 39 weeks, often induced
- Vaginal delivery is generally preferred; cesarean for obstetric indications including suspected macrosomia (~4500 g threshold)
- Insulin management during labor — IV insulin and dextrose protocols common
- Tight intrapartum glucose (70 to 110 mg/dL) reduces neonatal hypoglycemia
- Immediate postpartum insulin requirements drop sharply — pump basal rates often halved at delivery
Postpartum and Breastfeeding
- Insulin requirements drop to or below pre-pregnancy levels immediately after delivery of the placenta
- Breastfeeding women often need 10 to 20 percent less insulin
- Hypoglycemia risk higher in early postpartum and during breastfeeding
- Snacks before or during breastfeeding sessions
- Sleep deprivation worsens glucose patterns
- Contraception discussion before discharge
- Postpartum mental health screening
- See companion article on postpartum diabetes care and diabetes and breastfeeding
When to Seek Specialist Input
- Planning pregnancy — start working with the team 3 to 6 months before
- Pregnancy confirmed — immediately notify endocrinology and OB
- A1C not at target — work on plan, use reliable contraception meanwhile
- Severe nausea/vomiting (hyperemesis) affecting glucose control
- Suspected DKA — even at modest glucose readings
- Worsening retinopathy or nephropathy
- Hypoglycemia unawareness developing
- Concerns about fetal growth or movement
The Bottom Line
Pregnancy with type 1 diabetes is safest when planned — pre-pregnancy A1C below 6.5 percent (some specialists target below 6.0 percent), folate supplementation, medication review, and complication screening substantially reduce risks of congenital anomalies and miscarriage. Insulin requirements drop modestly in the first trimester (raising hypoglycemia risk), then rise 50 to 100 percent by the third trimester. CGM use is strongly recommended based on CONCEPTT trial evidence. Pregnancy-specific glucose targets are tighter — fasting under 95 mg/dL, 1-hour post-meal under 140 mg/dL, time in range above 70 percent. Insulin pumps, including hybrid closed-loop systems with pregnancy-specific algorithms (Tandem Control-IQ pregnancy mode), are widely used. Multidisciplinary care — endocrinologist, maternal-fetal medicine specialist, diabetes educator, ophthalmologist — produces the best outcomes. Talk to your endocrinologist and a maternal-fetal medicine specialist before conception, not after, to give yourself and your baby the strongest start. For pregnancy in type 2 diabetes see our companion article on pregnancy with type 2 diabetes.
